Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan

Journal of Medical Virology

Volumn 70, Issue 1, 2003, Pages 74-80

  Lu, Sheng Nan ^a,c   Chen, Tsung Ming ^a   Lee, Chuan Mo ^a   Wang, Jing Houng ^a   Tung, Hung Da ^a   Wu, Jaw Ching ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

HCV, HDV endemic community; Hepatitis virus B, C, D; Molecular epidemiology

Indexed keywords

VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; ENDEMIC DISEASE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN; VIRUS DETECTION; VIRUS HEPATITIS; VIRUS INFECTION;

FEMALE; GENOTYPE; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; TAIWAN;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS;

EID: 0037401390     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10361     Document Type: Article

References (46)

1. Arakawa Y, Moriyama M, Taira M, Hayashi N, Tanaka N, Okubo H, Sugitani M. 2000. Molecular analysis of hepatitis D virus infection in Miyako Island, a small Japanese island. J Viral Hepatol 7:375-381.
2. Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL. 1993. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci USA 90:9016-9020.
3. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, Liang DC, Shau WY, Chen DS. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 336:1855-1859.
4. Chao YC, Lee CM, Tang HS, Govindarajan S, Lai MM. 1991. Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. Hepatology 13:345-352.
5. Chen DS, Lai MY, Sung JL. 1984. Delta agent infection in patients with chronic liver diseases and hepatocellular carcinoma - an infrequent finding in Taiwan. Hepatology 4:502-503.
6. Chen CJ, Hwang SJ, Fan KY, Chang SA, Chang YH, Wang SR, Liu WT, Liaw YF, Chai CY, Chang R, Ho M. 1988. Seroepidemiology of human T lymphotropic viruses and hepatitis viruses among prostitutes in Taiwan. J Infect Dis 158:633-635.
7. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ, Hahn LC, Choo QL, Wang TH, Houghton M. 1990. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 162:817-822.
8. Chen IL, Lu SN, Wu CL. 1999. Anti-HCV prevalence among villages in an endemic township: a community study in Tzukuan, Kaohsiung. Chinese J Pub Health 18:313-318. [in Chinese]
9. Chuang WL, Chang WY, Lu SN, Su WP, Lin ZY, Chen SC, Hsieh MY, Wang LY, You SL, Chen CJ. 1992. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 69:2052-2054.
10. Chung DC, Ko YC, Chen CJ, Wu CC, Chen ER, Liaw YF, Hwang SJ. 1988. Seroepidemiological studies on hepatitis B and D viruses infection among five ethnic groups in southern Taiwan. J Med Virol 26:411-418.
11. el Gohary A, Hassan A, Nooman Z, Lavanchy D, Mayerat C, el Ayat A, Fawaz N, Gobran F, Ahmed M, Kawano F, Kiyokawa T, Yamaguchi K. 1995. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta Trop 59:155-161.
12. Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. 2000. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 46:420-426.
13. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, Lobello S, Sagnelli E, Brunetto MR, Rizzetto M. 2000. Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology 32:824-827.
14. Hadziyannis SJ, Dourakis SP, Papaioannou C, Alexopoulou A, Hadziyannis ES, Gioustozi A. 1993. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece. Prog Clin Biol Res 382:259-266.
15. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, Lee SD. 1997. Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 12:747-751.
16. Imazeki F, Omata M, Ohto M. 1990. Heterogeneity and evolution rates of delta virus RNA sequences. J Virol 64:5594-5599.
17. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, Esteban R, Guardia J. 2001. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 34:404-410.
18. Kao JH, Chen PJ, Lai MY, Chen DS. 2002. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C. J Clin Microbiol 40:22-25.
19. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, Imai H, Nakano Y, Usuda S, Uemura K, Furuta S, Watanabe Y, Watanabe J, Fukuda Y, Takayama T and the South Kiso Hepatitis Study Group. 1994. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology 106:1596-1602.
20. Lee SD, Wang JY, Wu JC, Chiang YT, Tsai YT, Lo KJ. 1986. Hepatitis B and D virus infection among drug abusers in Taiwan. J Med Virol 20:247-252.
21. Lee CM, Changchien CS, Chung JC, Liaw YF. 1996. Characterization of a new genotype II hepatitis delta virus from Taiwan. J Med Virol 49:145-154.
22. Lee CM, Lu SN, Changchien CS, Yeh CT, Hsu TT, Tang JH, Wang JH, Lin DY, Chen CL, Chen WJ. 1999. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection. Cancer 86:1143-1150.
23. Liaw YF, Yeh CT, Tsai SL. 2000. Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 95:2978-2980.
24. Louis FJ, Maubert B, Le Hesran JY, Kemmegne J, Delaporte E, Louis JP. 1994. High prevalence of anti-hepatitis C virus antibodies in a Cameroon rural forest area. Trans R Soc Trop Med Hyg 88:53-54.
25. Lu SN, Chue PY, Chen HC, Wu MH, Chen IL, Huang JF, Wang JH, Peng CF, Shih CH, You SL, Lu CF, Chen CJ, Chang WY. 1997a. Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan. J Gastroenterol Hepatol 12:547-550.
26. Lu SN, Chue PY, Chen IL, Wang JH, Huang JF, Peng CF, Shih CH, Chang WY. 1997b. Incidence of hepatitis C infection in a hepatitis C endemic township in southern Taiwan. Kaohsiung J Med Sci 13:605-608.
27. Lu SN, Chen HC, Tang CM, Wu MH, Yu ML, Chuang WL, Lu CF, Chang WY, Chen CJ. 1998. Prevalence and manifestations of hepatitis C seropositivity in children in an endemic area. Pediatr Infect Dis J 17:142-145.
28. Lu SN, Lee CM, Changchien CS, Chen CJ. 1999. Excess mortality from hepatocellular carcinoma in an HCV-endemic township of an HBV-endemic country (Taiwan). Trans R Soc Trop Med Hyg 93:600-602.
29. Lu SN, Wang JH, Kuo YK, Kuo SL, Chen TM, Tung HD, Lee CN. 2002. Predicting the prevalence of anti-HCV in a community using the prevalence of alanine transaminase (ALT) elevation - a method to identify HCV-endemic areas. Am J Trop Med Hyg 67:145-150.
30. Makino S, Chang MF, Shieh CK, Kamahora T, Vannier DM, Govindarajan S, Lai MM. 1987. Molecular cloning and sequencing of a human hepatitis delta virus RNA. Nature 329:343-346.
31. Mathurin P, Thibault V, Kadidja K, Ganne-Carrie N, Moussalli J, El Younsi M, Di Martino V, Lunel F, Charlotte F, Vidaud M, Opolon P, Poynard T. 2000. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatitic infections. J Viral Hepatol 7:15-22.
32. Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, Robertson BH. 1999. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 450:66-71.
33. Pawlotsky JM. 2002. Molecular diagnosis of viral hepatitis. Gastroenterology 122:1554-1568.
34. Sagnelli E, Coppola N, Scolastico C, Filippini P, Santantonio T, Stroffolini T, Piccinino F. 2000. Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis. Hepatology 32:1106-1110.
35. Sakugawa H, Nakasone H, Kawakami Y, Adaniya H, Mizushima T, Nakayoshi T, Kinjo F, Saito A, Zukeran H, Miyagi Y, Yakabi S, Taira M, Kinoshita M, Yamakawa Y. 1997. Determination of hepatitis delta virus (HDV)-RNA in asymptomatic cases of HDV infection. Am J Gastroenterol 92:2232-2236.
36. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Miyazato S, Kinjo F, Saito A, Ma SP, Hotta H, Kinoshita M. 1999. Hepatitis delta virus genotype IIb predominates in an endemic area, Okinawa, Japan. J Med Virol 58:366-372.
37. Wang CS, Chang TT, Chou P. 1998a. Differing characteristics of hepatitis B and C risk factors among elders in a rural area in Taiwan. J Gerontol A Biol Sci Med Sci 53:M107-M111.
38. Wang CS, Chang TT, Chou P. 1998b. Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan. J Clin Epidemiol 51:733-738.
39. Wang JH, Lu SN, Wu JC, Huang JF, Yu ML, Chen SC, Chuang WL. 1999. A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan. Trans R Soc Trop Med Hyg 93:253-254.
40. Wu JC, Lee SD, Govindarajan S, Lin HC, Chou P, Wang YJ, Lee SY, Tsai YT, Lo KJ, Ting LP. 1990. Sexual transmission of hepatitis D virus infection in Taiwan. Hepatology 11:1057-1061.
41. Wu JC, Chen CM, Sheen IJ, Lee SD, Tzeng HM, Choo KB. 1995a. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology 22:1656-1660.
42. Wu JC, Chen TZ, Huang YS, Yen FS, Ting LT, Sheng WY, Tsay SH, Lee SD. 1995b. Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. Gastroenterology 108:796-802.
43. Wu JC, Chiang TY, Sheen IJ. 1998. Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. J Gen Virol 79:1105-1113.
44. Wu JC, Chiang TY, Shiue WK, Wang SY, Sheen IJ, Huang YH, Syu WJ. 1999. Recombination of hepatitis D virus RNA sequences and its implications. Mol Biol Evol 16:1622-1632.
45. Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. 1991. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 51:5621-5625.
46. Yu ML, Chuang WL, Chen SC, Dai CY, Hou C, Wang JH, Lu SN, Huang JF, Lin ZY, Hsieh MY, Tsai JF, Wang LY, Chang WY. 2001. Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol 65:58-65.